Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|June 2, 2021
Antibody-Drug Conjugates-A Tutorial ReviewStephanie Baah, Mark Laws, Khondaker Miraz Rahman
Trends in Microbiology|May 30, 2021
Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistanceMark Laws, Peiqin Jin, Khondaker Miraz Rahman
FEMS Microbiology Reviews|June 1, 2019
Antibiotic resistance breakers: current approaches and future directionsMark Laws, Ali Shaaban, Khondaker Miraz Rahman
Npj Antimicrobials and Resistance|June 11, 2025
Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteriaNupur Gargate, Mark Laws, Khondaker Miraz Rahman
Drug Discovery Today|October 1, 2021
Factors influencing the choice of monoclonal antibodies for antibody-drug conjugatesMd Mahbub Hasan, Mark Laws, Peiqin Jin, et al.
ACS Omega|June 18, 2020
N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative BacteriaMark Laws, Charlotte Hind, Andrea Favaron, et al.
Bulletin of the World Health Organization|August 4, 2022
Reclassifying contraceptives as over-the-counter medicines to improve accessAnne Ammerdorffer, Mark Laws, Manjulaa Narasimhan, et al.
ACS Omega|December 24, 2019
Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosisPietro Picconi, Rose Jeeves, Christopher William Moon, et al.
Environmental Research|November 6, 2020
Increased plant species richness associates with greater soil bacterial diversity in urban green spacesZdravko Baruch, Craig Liddicoat, Christian Cando-Dumancela, et al.
Health Research Policy and Systems|April 22, 2021
Regulatory standards and processes for over-the-counter availability of hormonal contraception and drugs for medical abortion in five countries in the Eastern Mediterranean RegionAnne Ammerdorffer, Mark Laws, Arinze Awiligwe, et al.
Pageof 2